Perspective Therapeutics (Acquired) Overview
- Year Founded
-
2015

- Status
-
Acquired/Merged
- Employees
-
80

- Latest Deal Type
-
M&A
Perspective Therapeutics (Acquired) General Information
Description
Developer of a radiopharmaceutical company intended to treat cancer. The company's pipeline of oncology therapeutics, diagnostic imaging agents, and lead (Pb)-212-based alpha-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells with specialized targeting peptides, enabling health professionals to utilize the same targeting peptide for the purpose of personalizing treatment and optimizing patient outcomes.
Contact Information
(Operating Subsidiary)
Corporate Office
- 2401 Elliott Avenue
- Suite 320
- Seattle, WA 98121
- United States
Corporate Office
- 2401 Elliott Avenue
- Suite 320
- Seattle, WA 98121
- United States
Perspective Therapeutics (Acquired) Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Merger/Acquisition | 07-Feb-2023 | Completed | Clinical Trials - Phase 1 | |||
7. Grant | 31-Aug-2022 | Completed | Generating Revenue | |||
6. Later Stage VC (Series A) | 14-Jan-2021 | Completed | Generating Revenue | |||
5. Grant | 07-Sep-2020 | Completed | Generating Revenue | |||
4. Grant | 20-Sep-2019 | Completed | Generating Revenue | |||
3. Grant | 08-Sep-2017 | Completed | Generating Revenue | |||
2. Grant | 19-Jan-2017 | $1.02M | Completed | Startup | ||
1. Grant | 31-Aug-2016 | $1.2M | Completed | Startup |
Perspective Therapeutics (Acquired) Comparisons
Industry
Financing
Details
Perspective Therapeutics (Acquired) Competitors (3)
One of Perspective Therapeutics (Acquired)’s 3 competitors is Perspective Therapeutics, a Formerly VC-backed company based in Seattle, WA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Perspective Therapeutics | Formerly VC-backed | Seattle, WA | ||||
RadioMedix | Venture Capital-Backed | Houston, TX | ||||
RefleXion (Biotechnology) | Venture Capital-Backed | Hayward, CA |
Perspective Therapeutics (Acquired) Patents
Perspective Therapeutics (Acquired) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240091705-A1 | Removal of free-unlabeled cationic and anionic solution phase radionuclides from radiopharmaceuticals using solid-phase extraction techniques | Pending | 16-Sep-2022 |
Perspective Therapeutics (Acquired) Signals
Perspective Therapeutics (Acquired) Former Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Iowa Economic Development Authority | Government | |||
Iowa Seed Fund | Venture Capital | Minority | ||
NIH Seed | Not-For-Profit Venture Capital | |||
National Cancer Institute | Government | |||
National Institutes of Health | Government |
Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Isoray Medical (Brachytherapy Business Division) | Coralville, IA |
Perspective Therapeutics (Acquired) FAQs
-
When was Perspective Therapeutics (Acquired) founded?
Perspective Therapeutics (Acquired) was founded in 2015.
-
Where is Perspective Therapeutics (Acquired) headquartered?
Perspective Therapeutics (Acquired) is headquartered in Seattle, WA.
-
What is the size of Perspective Therapeutics (Acquired)?
Perspective Therapeutics (Acquired) has 80 total employees.
-
What industry is Perspective Therapeutics (Acquired) in?
Perspective Therapeutics (Acquired)’s primary industry is Drug Discovery.
-
Is Perspective Therapeutics (Acquired) a private or public company?
Perspective Therapeutics (Acquired) is a Private company.
-
What is Perspective Therapeutics (Acquired)’s current revenue?
The current revenue for Perspective Therapeutics (Acquired) is
. -
How much funding has Perspective Therapeutics (Acquired) raised over time?
Perspective Therapeutics (Acquired) has raised $14.3M.
-
Who are Perspective Therapeutics (Acquired)’s investors?
Iowa Economic Development Authority, Iowa Seed Fund, NIH Seed, National Cancer Institute, and National Institutes of Health are 5 of 8 investors who have invested in Perspective Therapeutics (Acquired).
-
Who are Perspective Therapeutics (Acquired)’s competitors?
Perspective Therapeutics, RadioMedix, and RefleXion (Biotechnology) are competitors of Perspective Therapeutics (Acquired).
-
When was Perspective Therapeutics (Acquired) acquired?
Perspective Therapeutics (Acquired) was acquired on 07-Feb-2023.
-
Who acquired Perspective Therapeutics (Acquired)?
Perspective Therapeutics (Acquired) was acquired by Perspective Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »